Figure 3From: Incentives for new antibiotics: the Options Market for Antibiotics (OMA) modelTimeline of drug approval with corresponding examples of call options pricing. A: Investment in early stage of development, the cost of the call option is low, but the risk is high. B: Investment in late stage of development, the cost of the call option is high, but the risk is low.Back to article page